Clinical Trial Update: Interest of Continuous Subcutaneous Apomorphine in Parkinsonian Patients at the End of Life

View source ↗

Summary

This clinical trial investigates the feasibility and potential benefits of continuous subcutaneous apomorphine in Parkinson's disease patients at the end of lif…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Apomorphine (apomorphine)

Snippet

Sponsor: Centre Hospitalier Régional d'Orléans | Conditions: Parkinson Disease | Status: RECRUITING